ISOCARBOXAZID (MARPLAN) IN AMBULATORY PSYCHIATRIC PATIENTS
Abstract
Isocarboxazid appears to be a very workable hydrazine derivative for treating ambulatory depressions, and is of use as well in certain cases of schizophrenia. Relatively high doses are possible with relatively few side effects. The isocarboxazid for this study was supplied by Roche Laboratories (trademark, Marplan).
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
